Boston Scientific Wins FDA Approval for Imaged-Guided Software for DBS Therapy

Posted on April 13, 2022

Boston Scientific (NYSE:BSX) today announced it received FDA approval for its Vercise Neural Navigator with StimView XT. The Marlborough, Massachusetts–based company designed its latest image-guided programming software in collaboration with Brainlab AG. It enables clinicians in real-time to visualize lead placement and stimulation modeling of the brain anatomy of patients with Parkinson’s disease or essential tremor.

Categories: In the News